UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Samsung BioLogics files administrative suit to refute accounting fraud ruling
Samsung BioLogics said it filed an administrative suit on Nov. 14 to nullif...
by Nam Doo-hyun
|
2018-11-28 15:30
라인
Bayer’s liver cancer drug proves efficacy with real-world data
Bayer Korea said it has confirmed the clinical efficacy and tolerability of...
by Nam Doo-hyun
|
2018-11-27 14:27
라인
Pharmaceuticals, biotechs rise with KOSPI rebound
Shares of pharmaceutical and biotech companies moved up briskly on Monday, ...
by Nam Doo-hyun
|
2018-11-27 11:53
라인
Pharmaceuticals still use credit card kiting for illegal cash rebates
With the government’s stricter crackdown on illegal rebates, Korean pharmac...
by Nam Doo-hyun
|
2018-11-26 15:01
라인
Operating income declines at top 10 biotechs on KOSDAQ
Top 10 biotech companies on the secondary KOSDAQ market posted significant ...
by Nam Doo-hyun
|
2018-11-22 11:15
라인
US data crucial for Korean biosimilars after success in Europe
Korean biosimilar makers will find it more critical to achieve meaningful r...
by Nam Doo-hyun
|
2018-11-21 15:29
라인
MSD Korea improves employee welfare upon birth of union
Workers at MSD Korea said they have formed a labor union to curb the manage...
by Nam Doo-hyun
|
2018-11-21 12:56
라인
‘Pay attention to expansion of US online pharmacy market’
The online pharmacy market is rapidly expanding around the world at such a ...
by Nam Doo-hyun
|
2018-11-20 16:05
라인
Samsung BioLogics fiasco hardly affects biotech stocks
The suspension of trading of Samsung BioLogics shares did not have a much n...
by Nam Doo-hyun
|
2018-11-16 11:30
라인
‘Team up with multinationals to become multinational’
Korean biotech and pharmaceutical businesses should cooperate with multinat...
by Nam Doo-hyun
|
2018-11-15 11:20
라인
Seoul mayor vows to support biomedical industry
The Seoul Metropolitan Government said it would become the hub of the natio...
by Nam Doo-hyun
|
2018-11-14 15:34
라인
Orders for ingredients of antitussives, expectorants surge amid fine dust
Orders for active pharmaceutical ingredients (API) for cough suppressants a...
by Nam Doo-hyun
|
2018-11-14 11:48
라인
Pharmaceuticals oppose Korea-US FTA’s follow-up steps
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPMA) sh...
by Nam Doo-hyun/So Jae-hyeon
|
2018-11-12 15:53
라인
'Biosimilar makers to benefit from new research accounting guideline'
The Financial Supervisory Service’s recent guidelines for research and deve...
by Nam Doo-hyun
|
2018-11-07 11:23
라인
Market caps of top 20 drugmakers on KOSPI surged this year
Market capitalizations of high-ranking pharmaceutical and biotech companies...
by Nam Doo-hyun
|
2018-11-06 15:41
라인
Will PharmAbcine be new force on KOSDAQ?
PharmAbcine, an immuno-oncology company, might be a promising biotech firm ...
by Nam Doo-hyun
|
2018-11-05 16:32
라인
‘Physicians’ ability to analyze big data, use AI getting crucial’
With precision medicine industry expected to grow rapidly with the advancem...
by Nam Doo-hyun
|
2018-11-01 16:22
라인
Oriental medical schools fail to get listed on world directory of medical schools
The local Oriental medicine community recently faced a major setback, faili...
by Nam Doo-hyun
|
2018-11-01 15:52
라인
'More N. Korean statistics needed for inter-Korean healthcare cooperation’
To prepare well for inter-Korean cooperation in the healthcare sector, Sout...
by Nam Doo-hyun
|
2018-10-31 15:10
라인
Korea’s drug exports to US inch down this year
Korea’s exports of pharmaceutical products to the U.S. slightly went down i...
by Nam Doo-hyun
|
2018-10-31 12:22
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top